REFERENCES
- Bujanover Y, Reif S, Yahav J. Helicobacter pylori and peptic disease in the pediatric patient. Pediatr Clin North Am. 1996;43:213–234.
- Hill ID, Sinclair-Smith C, Lastovica AJ, Transient protein losing enteropathy associated with acute gastritis and Campylobacter pylori. Arch Dis Child. 1987;62:1215–1219.
- Sullivan PB, Thomas JE, Wight DGD, et al. Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child. 1990;65:189–191.
- Perri F, Pastore M, Leandro G, Helicobacter pylori infection and growth delay in older children. Arch Dis Child. 1997;77:46–49.
- Dufour C, Brisigotti M, Fabretti G, Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17:225–227.
- DuBois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol. 2005;100:453–459.
- Cherian S, Forbes DA, Cook AG, An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One. 2008;3:e4030, 1–8.
- Pellicano R, Rizzetto M. Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal. Panminerva Med. 2004;46:165–169.
- Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788.
- Beutler E. Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis. Blood Cells Mol Dis. 2007;38:54–55.
- World Health Organization, United Nations Children's Fund, and United Nations University. Iron deficiency anaemia: assessment, prevention, and control. A Guide for Programme Managers. Geneva: 2001;1–132. Available at: https://apps.who.int/nut/publications.htm.
- Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117:4425–4433.
- Sanad M, Gharib AF. Urinary hepcidin level as an early predictor of iron deficiency in children: a case control study. Ital J Pediatr. 2011;37:37. Available at: http://www.ijponline.net/content/37/1/37.
- Bergamaschi G, Di Sabatino A, Albertini R, Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199–205.
- Kaya Z, Yildiz E, Gursel T, Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia. J Trop Pediatr. 2011;57:120–125.
- Nagy J, Lakner L, Poór VS, Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis. 2010;4:649–653.
- Sasu BJ, Li H, Rose MJ, Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol Dis. 2010;45(3):238–245.
- Barrios Y, Espinoza M, Barón MA. Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin. Nutr Hosp. 2010;25:555–560.
- Kaplan M, Erikci AA, Ozturk A, Serum prohepcidin in pulmonary tuberculosis. Hematology. 2009;14:245–248.
- Kemna E, Pickkers P, Nemeth E, Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005;106:1864–1866.
- Lee SY, Song EY, Yun YM, Serum prohepcidin levels in Helicobacter pylori infected patients with iron deficiency anemia. Korean J Intern Med. 2010;25:195–200.
- Baysoy G, Ertem D, Ademoğlu E, Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2004;38:146–151.